1.. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
Am J Kidney Dis 2004;44(4):642-50.
2.. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
JAMA 2008;300(8):924-32.
3.. Strasak A, Ruttmann E, Brant L, Kelleher C, Klenk J, Concin H, et al. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men.
Clin Chem 2008;54(2):273-84.
4.. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome.
Am J Physiol Renal Physiol 2006;290(3):F625-31.
5.. Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.
Arthritis Care Res (Hoboken) 2012;64(10):1431-46.
6.. Roddy E, Doherty M. Epidemiology of gout.
Arthritis Res Ther 2010;12(6):223.
7.. Selhub J. Homocysteine metabolism.
Annu Rev Nutr 1999;19:217-46.
8.. McCully KS. Homocysteine and vascular disease.
Nat Med 1996;2(4):386-9.
9.. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence.
Ann Intern Med 1999;131(5):363-75.
10.. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease.
Annu Rev Med 1998;49(1):31-62.
11.. Nygård O, Vollset SE, Refsum H, Brattström L, Ueland PM. Total homocysteine and cardiovascular disease.
J Intern Med 1999;246(5):425-54.
13.. Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P, et al. Role of blood pressure, uric acid, and hemorheo-logical parameters on plasma homocyst(e)ine concentration.
Atherosclerosis 1995;114(2):175-83.
14.. Tsutsumi Z, Moriwaki Y, Yamamoto T, Takahashi S, Hada T, Fukuchi M. Total plasma homocysteine is not increased in Japanese patients with gout.
J Rheumatol 2002;29(8):1805-6.
16.. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology.
Proc Nutr Soc 2004;63(1):49-63.
17.. Suh HS, Kim JS, Kim SS, Jung JG, Yoon SJ, Ahn JB. Influence of the Flushing Response in the Relationship between Alcohol Consumption and Cardiovascular Disease Risk.
Korean J Fam Med 2014;35(6):295-302.
18.. Jung JG, Kim JS, Kim YS, Oh MK, Yoon SJ. Hypertension associated with alcohol consumption based on the facial flushing reaction to drinking.
Alcohol Clin Exp Res 2014;38(4):1020-5.
19.. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity.
J Chronic Dis 1972;25(6):329-43.
20.. National Institute on Alcohol Abuse and Alcoholism. Alcohol screening and brief intervention for youth: A practitioner's guide. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2011. [Accessed February 28, 2015].. http://pubs.niaaa.nih.gov/publications/Practitioner/YouthGuide/YouthGuide.pdf.
21.. Yokoyama A, Muramatsu T, Ohmori T, Kumagai Y, Higuchi S, Ishii H. Reliability of a flushing questionnaire and the ethanol patch test in screening for inactive aldehyde dehydrogenase-2 and alcohol-related cancer risk.
Cancer Epidemiol Biomarkers Prev 1997;6(12):1105-7.
22.. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate.
Ann Intern Med 2009;150(9):604-12.
23.. Kim EC, Kim JS, Jung JG, Kim SS, Yoon SJ, Ryu JS. Effect of alcohol consumption on risk of hyperhomocysteinemia based on alcohol-related facial flushing response.
Korean J Fam Med 2013;34(4):250-7.
24.. Emmerson B. Hyperlipidaemia in hyperuricaemia and gout.
Ann Rheum Dis 1998;57(9):509-10.
25.. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.
Diabetes Care 2001;24(8):1403-10.
26.. Papezikova I, Pekarova M, Lojek A, Kubala L. The effect of uric acid on homocysteine-induced endothelial dysfunction in bovine aortic endothelial cells.
Neuro Endocrinol Lett 2009;30(Suppl 1):112-5.
28.. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?
Atherosclerosis 2000;148(1):131-9.
29.. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.
JAMA 2000;283(18):2404-10.
30.. Barak AJ, Beckenhauer HC, Tuma DJ. Methionine synthase. a possible prime site of the ethanolic lesion in liver.
Alcohol 2002;26(2):65-7.
31.. Brecher AS, Lehti MD. A hypothesis linking hypoglycemia, hyperuricemia, lactic acidemia, and reduced gluconeogenesis in al-coholics to inactivation of glucose-6-phosphatase activity by acetaldehyde.
Alcohol 1996;13(6):553-7.